Chronic Disease
Conditions
Brief summary
Objectives of the study are: * The validation of the GMAS questionnaire in patients with chronic disease. * Measurement of the level of therapeutic adherence in patients with chronic illness. * Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial.
Detailed description
The research is multicentre and will be conducted at the Fondazione Policlinico Gemelli IRCCS in Rome as reference centre together with the other participating centres. Patients will be enrolled at the centres involved, either during visits or during their hospital stay.
Interventions
OTHERValidation of questionnaire
Validation of questionnaire
Sponsors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Chronically ill; * Age 18 years or older; * Willingness to participate in the study; * Chronic illness diagnosed at least 3 months before the start of the study; * Reading and signing the informed consent.
Exclusion criteria
* Reduced command of the Italian language; * Subjects suffering from severe psychiatric disorders; * Serious clinical conditions that do not permit completion of the questionnaire; * Refusal to sign the informed consent to participate in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The validation of the GMAS questionnaire in patients with chronic disease. | 1 year | The validation of the GMAS questionnaire in patients with chronic disease. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of the level of therapeutic adherence in patients with chronic illness. Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial. | 1 year | Measurement of the level of therapeutic adherence in patients with chronic illness. Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial. |
Countries
Italy
Outcome results
None listed